Appleton Partners Inc. MA Sells 2,412 Shares of Procter & Gamble Company (The) $PG

Appleton Partners Inc. MA lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 3.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,704 shares of the company’s stock after selling 2,412 shares during the quarter. Appleton Partners Inc. MA’s holdings in Procter & Gamble were worth $10,149,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC grew its position in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Northern Trust Corp grew its position in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after buying an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after buying an additional 1,018,865 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.1%

Procter & Gamble stock opened at $152.19 on Monday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The stock has a market capitalization of $356.20 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The business’s fifty day moving average is $155.51 and its 200 day moving average is $159.95.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm posted $1.40 earnings per share. Procter & Gamble’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble’s dividend payout ratio is currently 64.82%.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at approximately $50,228,106.25. This represents a 11.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last 90 days. Insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on PG shares. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Barclays cut their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research note on Saturday, September 27th. BNP Paribas Exane cut their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Finally, BNP Paribas reissued an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $173.11.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.